SolveLetter

Monthly insights on evidence strategy, medical communications, and AI tools for pharma teams.
Get SolveLetter in your inbox
1–2 articles per month. No spam. Unsubscribe anytime.
Join 1,200+ pharma professionals. Free forever.
Category
All AI Tools Advisory Boards Evidence Strategy KOL Engagement
Newsletter
Get SolveLetter monthly in your inbox
Evidence strategy, advisory board insights, AI tools, and regulatory updates — curated for pharma medical affairs teams.
1–2 articles per month, never more
Practical insights from real projects
Free forever, unsubscribe anytime
Subscribe to SolveLetter
Join 1,200+ pharma professionals. No spam.
Evidence Scanner
Evidence ScannerTM
AI infrastructure

AI-powered.
Expert-validated.

We built AI workflows into our daily practice — not as a marketing claim, but as the infrastructure that lets our medical experts deliver faster without cutting corners.

Research
Structured PubMed queries with narrative or table outputs
Monitoring
Weekly literature digests by drug, target, or topic
AI-Enhanced EDC
Advisory board transcription + structured AI summary
Fact-Checker
Claim verification against your source documents
AI accelerates. Our experts validate.
Every output goes through expert medical review before it reaches your team. AI handles structure and speed — we handle scientific judgement and MLR readiness.
Evidence Scanner · Monitoring module
// Weekly digest: GLP-1 RA publications
monitor("GLP-1 receptor agonist", {
  frequency: "weekly",
  sources: ["pubmed", "congress_abstracts"]
})
Scanning 12 sources...
Weekly Digest · Feb 24–Mar 2
7 new publications found. 2 RCTs, 3 RWE studies, 2 meta-analyses. Key finding: MACE benefit confirmed in CVOT pooled analysis. Competitive alert: new data on tirzepatide...